Atlas Trials

Magnesium Sulfate as an Adjuvant to Lidocaine in MPDS Trigger Point Injections Assessed by VAS and sEMG.

Clinical trial NCT07390851 · RECRUITING

Trial details

NCT number
NCT07390851
Sponsor
Cairo University
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Myofascial Pain Dysfunction Syndrome
Start date
2025-11-26
Primary completion
2026-11-26
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.